Dérivés de Quinazoline et de Quinoléine
Les quinazolines et les quinoléines sont des composés hétérocycliques azotés à structure aromatique qui jouent un rôle clé dans la synthèse de médicaments à activité anticancéreuse, antimicrobienne et anti-inflammatoire. Leurs dérivés présentent des modifications structurelles qui optimisent leur biodisponibilité et leur sélectivité, permettant ainsi le développement de nouveaux principes actifs pour diverses applications thérapeutiques. Ces composés sont utilisés dans la fabrication d’API destinés au traitement du cancer, des infections, des maladies neurodégénératives et cardiovasculaires. De plus, les dérivés de quinazoline et de quinoléine sont essentiels dans la recherche d’inhibiteurs enzymatiques et dans la conception de molécules bioactives innovantes.
Chez CymitQuimica, nous proposons des dérivés de quinazoline et de quinoléine de haute pureté pour des applications en synthèse chimique, développement pharmaceutique et biotechnologie.
65630 produits trouvés pour "Dérivés de Quinazoline et de Quinoléine"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Metoprolol Related Compound E (3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol)
CAS :Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C12H18O4Couleur et forme :White Coarse Powder Semi-SolidMasse moléculaire :226.12051Bendroflumethiazide
CAS :Sulfonamides used as drugsFormule :C15H14F3N3O4S2Couleur et forme :PowderMasse moléculaire :421.42Sorbitol
CAS :D-glucitol (sorbitol)Formule :C6H14O6Couleur et forme :White Crystalline PowderMasse moléculaire :182.17 g/molNorepinephrine Related Compound D ((R)-4-(2-Amino-1-methoxyethyl)benzene-1,2-diol bitartrate hydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C9H13NO3·C4H6O6·H2OCouleur et forme :Light Brown Off-White SolidMasse moléculaire :183.08954Ambrisentan Related Compound E (4,6-Dimethylpyrimidin-2-ol)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C6H8N2OCouleur et forme :White Off-White Pale Yellow Crystalline PowderMasse moléculaire :124.06366N-Nitroso Dabigatran Etexilate Solution (1 mL ) (ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H40N8O6Couleur et forme :Colorless LiquidMasse moléculaire :656.30708Rotigotine O-Tosylate Hydrochloride ((S)-6-(propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-yl 4-methylbenzenesulfonate hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C26H32ClNO3S2Couleur et forme :Off-White SolidMasse moléculaire :505.15121Omeprazole Magnesium
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H36MgN6O6S2Couleur et forme :White Off-White PowderMasse moléculaire :712.19882Celecoxib Open Ring (4-((1,1,1-trifluoro-4-hydroxy-4-(p-tolyl)but-3-en-2-ylidene)amino)benzenesulfonamide)
Sulfonamides, nesoiFormule :C17H15F3N2O3SCouleur et forme :Yellow SolidMasse moléculaire :384.37Clioquinol
CAS :Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormule :C9H5ClINOCouleur et forme :PowderMasse moléculaire :304.91044Duloxetine Hydrochloride
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19NOS·HClCouleur et forme :White Off-White PowderMasse moléculaire :297.11874Carbamazepine Dione (10,11-dioxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C15H10N2O3Couleur et forme :Greenish-Yellow SolidMasse moléculaire :266.06914Carvedilol Bisalkylpyrocatechol derivative (3,3'-{2,2'-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C40H42N4O6Couleur et forme :Off-White Light Brown SolidMasse moléculaire :674.78Clozapine Resolution Mixture
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureCouleur et forme :Yellow Crystalline PowderMasse moléculaire :203.09061Omeprazole Related Compound E (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O4SCouleur et forme :Off-White PowderMasse moléculaire :361.109631,3-Bis(isopropylamino)propan-2-ol Dihydrochloride (1,3-bis(isopropylamino)propan-2-ol Dihydrochloride)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C9H24Cl2N2OCouleur et forme :White Off-White PowderMasse moléculaire :246.12657Carvedilol Related Compound A (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C36H43N3O7Couleur et forme :PowderMasse moléculaire :629.74Sorafenib Isopropyl Carbamate (Isopropyl {4-[2-(methylcarbamoyl)pyridin-4-yl]oxyphenyl}carbamate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O4Couleur et forme :Off-White PowderMasse moléculaire :329.13756Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C36H43NO6·H2OCouleur et forme :White SolidMasse moléculaire :603.3196Dehydroargatroban Trifluoroacetate ((2R,4R)-4-Methyl-1-{[(3-methylquinolin-8-yl)sulfonyl]-L-arginyl}piperidine-2-carboxylic acid Trifluoroacetate)
Sulfonamides, nesoiFormule :C23H32N6O5S·C2HF3O2Couleur et forme :Off-White PowderMasse moléculaire :504.21549Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C25H37NO4Couleur et forme :Off-White Crystalline PowderMasse moléculaire :415.27226Oxcarbazepine Related Compound C (Acridin-9(10H)-one)
CAS :Aromatic or modified aromatic heterocyclic compounds wiFormule :C13H9NOCouleur et forme :Yellow Green SolidMasse moléculaire :195.06841Argatroban Related Compound A ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
CAS :Sulfonamides, nesoiFormule :C23H31N7O7SCouleur et forme :White PowderMasse moléculaire :549.20057Cyclam (1,4,8,11-Tetraazacyclotetradecane)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C10H24N4Couleur et forme :White Beige PowderMasse moléculaire :200.33 g/molAripiprazole Related Compound G (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one)
CAS :Lactams, nesoiFormule :C23H25Cl2N3O2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :445.13238Prasugrel Related Compound D (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18FNO2SCouleur et forme :Off-White PowderMasse moléculaire :331.10423N-Nitroso Bupropion (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS :Compounds with other nitrogen function, nesoiFormule :C13H17ClN2O2Couleur et forme :SolidMasse moléculaire :268.09786Desmethoxy Fluvoxamine Maleate ((E)-1-[4-(Trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime maleate)
CAS :Aromatic organic derivatives of hydrazine or of hydroxylamineFormule :C14H19F3N2O·C4H4O4Couleur et forme :White PowderMasse moléculaire :288.144954-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C17H21N·HClCouleur et forme :White Off-White SolidMasse moléculaire :239.1674Paroxetine System Suitability Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Off-White PowderBupropion Hydrochloride
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H18ClNO·HClCouleur et forme :White Off-White PowderMasse moléculaire :276.23-Chlorobenzoic Acid
CAS :Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormule :C7H5ClO2Couleur et forme :White PowderMasse moléculaire :156.57 g/molTeriflunomide
CAS :Nitrile function compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :White Crystalline PowderMasse moléculaire :270.06161Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSHClCouleur et forme :White Off-White PowderMasse moléculaire :315.16569Ambrisentan Related Compound D (2-[(2,2-Diphenylvinyl)oxy]-4,6-dimethylpyrimidine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C20H18N2OCouleur et forme :Off-White Fine PowderMasse moléculaire :302.14191Carvedilol Related Compound B (3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C39H39N3O6Couleur et forme :Off-White PowderMasse moléculaire :645.76 g/molBicalutamide
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C18H14F4N2O4SCouleur et forme :White Off-White PowderMasse moléculaire :430.06104Leflunomide
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :White PowderMasse moléculaire :270.06161Rotigotine Racemate ((RS)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H25NOSCouleur et forme :Off-White CrystalsMasse moléculaire :315.16569Celecoxib Related Compound A (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C17H14F3N3O2SCouleur et forme :White PowderMasse moléculaire :381.07588Labetalol Related Compound A (2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzoic acid hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C19H23NO4·HClCouleur et forme :Off-White SolidMasse moléculaire :365.139395-Hydroxymethylfurfural (5-(Hydroxymethyl)-2-furaldehyde)
CAS :Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C6H6O3Couleur et forme :Yellow SolidMasse moléculaire :126.03169Alcohol Determination - Alcohol
CAS :Other spirituous beverages, nesoiFormule :C2H6OCouleur et forme :Colorless Translucent LiquidMasse moléculaire :46.04186Carvedilol System Suitability Mixture (carvedilol spiked with carvedilol related compound F)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderRotigotine Related Compound K (7,8-Dihydronaphthalen-1-ol)
CAS :Monophenols not elsewhere specified or includedFormule :C10H10OCouleur et forme :White Grey Brown Crystalline SolidMasse moléculaire :146.07316Dabigatran Etexilate Related Compound A (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H40N6O6Couleur et forme :White SolidMasse moléculaire :628.30093Regular Bleached Shellac
CAS :Natural gums, gum resins, resins and balsams nesoiCouleur et forme :PowderAnhydrous Lactose (A Mixture of α and β anomers)
CAS :Lactose and lactose syrup, containing by weight 99% or more lactose, expressed as anhydrous lactose, calculated on the dry matterFormule :C12H22O11Couleur et forme :White Off-White PowderMasse moléculaire :342.11621Ondansetron
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C18H19N3OCouleur et forme :White Off-White PowderMasse moléculaire :293.15281Sirolimus
CAS :Antibiotics nesoiFormule :C51H79NO13Couleur et forme :Off-White White PowderMasse moléculaire :913.55514
